Searched for
SHREYA LIFE SCIENCES
Lenskart block deal; Meesho's kirana pushLenskart has drawn fresh interest from major institutional investors. This and more in today's ETtech Top 5.- Bombay HC backs GSK in Paxil trademark row against Shreya Life SciencesThe Indian subsidiary of the UK-based GSK PLC had urged the court to cancel the mark used by the local company in pharmaceutical and medici...
- JEE AIR 14, IIT Mumbai CS degree and now working in a cow shelter? An IIM grad sparks an online hunt for old IIT gradAn IIM alumnus's post about a former IIT JEE topper, reportedly ranked 14th, now working as a gaushala caretaker in Mumbai, has gone viral....
- Chennai IIT BS degree student, who used Covid lockdown to get two degrees, is a teaching assistant at Harvard today. Who is Shreya Singhal?During the pandemic, Shreya Singhal pursued a dual academic path, enrolling in an IIT Madras online Data Science program alongside her BCA ...
- Zoology enters DU’s top 3 undergraduate courses for first time, overtakes EnglishZoology (Hons) has surged in popularity at Delhi University, becoming a top-three program due to its interdisciplinary nature and relevance...
- US sanctions over 10 Indian entities among 275 for supporting Russia's military-industrial baseThe US has imposed sanctions on 275 individuals and entities, including Indian companies, for supporting Russia's military-industrial base ...
- How a Mumbai drugmaker is helping Putin get Nvidia AI chipsShreya Life Sciences in Mumbai exported Dell's advanced PowerEdge XE9680 servers containing Nvidia AI chips to Russia, bypassing Western sa...
- Chennai's Shreya Dharmarajan becomes UK high commissioner for a dayShreya Dharmarajan, a 21-year-old woman from Chennai, won a competition organized by the British High Commission in India and became the Br...
- Stock market update: 146 stocks hit 52-week lows on NSEDomestic benchmark index NSE Nifty was trading 179.90 points down at 11,631.25.
- India Inc raises $ 3.71 billion in July via ECB, FCCB routesIndia Inc raised over $ 3.71 bn from overseas markets in July through external commercial borrowings and foreign currency convertible bonds.
- Pharma cos to hike insulin prices by up to 15%Drug price regulator National Pharmaceutical Pricing Authority allows cos to up MRP of popular insulin brands by 15%.
- NPPA revision of 174 drug prices may lead to costlier medicinesInsulin brands, steroids and painkillers may become more expensive once NPPA revises prices of more than 170 medicines, in some cases by as...
- Insulin, cancer drugs will cost more soonPrices of various insulin brands and cancer drugs will soon increase while medicines for asthma, meningitis and diphtheria will become chea...
- Shreya group targeting over Rs 500-cr turnover this fiscalBio-pharma major, Russia-based Shreya group is targeting a turnover of more than Rs 500-crore this fiscal, a top company official said toda...
- Changing Prescription: NPPA revises prices of 149 medicinesThe NPPA has revised both ceiling and non-ceiling prices of medicines. It is learnt that prices in case of 14 formulation packs have been r...
- Generex gets CDSCO nod for non-injectable insulinUS-based Generex Biotechnology Corporation on Friday said it has received approval from the Central Drugs Standards Control Organisation (C...
- Cos slash prices of popular medicinesPopular medications to treat chest pain, anxiety, allergy and diabetes have become cheaper by between 2% and 39%.
- Govt plans 'realistic' norms on drug price monitoringLeading pharmaceutical companies, which have received government directives to cut the prices of their key price-control-free brands, can e...
- Two Ranbaxy drugs under NPPA scannerPharmaceutical major Ranbaxy’s two antibiotic formulation packs have come under drug price regulator National Pharmaceutical Pricing Author...
- Shreya Life, Wockhardt may cut prices of key brandsThe Mumbai-based Shreya Life Sciences and Wockhardt are about to face government pressure to reduce the price increases of some of their ke...
Load More
